T1	Concept 13 19	spread
T2	Concept 23 31	COVID-19
R1	in-context Arg1:T1 Arg2:T2	
T3	Concept 35 41	faster
R2	has-property Arg1:T1 Arg2:T3	
T4	Concept 47 51	SARS
R3	in-context Arg1:T3 Arg2:T4	
T5	Concept 93 99	spread
T6	Concept 100 108	dynamics
T7	Concept 82 92	complicate
R4	in-context Arg1:T6 Arg2:T5	
R5	has-property Arg1:T6 Arg2:T7	
R6	causes Arg1:T6 Arg2:T1	
T8	Concept 109 117	COVID-19
T9	Concept 183 189	people
T10	Concept 171 181	protection
T12	Action 204 212	infected
T13	Concept 222 229	contact
T14	Concept 216 221	close
R7	has-property Arg1:T13 Arg2:T14	
R8	in-context Arg1:T9 Arg2:T10	
A1	Negated T10
T11	Concept 137 147	contagious
T15	Concept 132 136	more
R9	has-property Arg1:T8 Arg2:T11	
R10	has-property Arg1:T11 Arg2:T15	
T16	Concept 153 157	SARS
R12	in-context Arg1:T11 Arg2:T16	
R11	causes Arg1:T13 Arg2:T12	
R13	target Arg1:T12 Arg2:T9	
R14	subject Arg1:T12 Arg2:T8	
T17	Concept 265 273	COVID-19
T18	Concept 274 282	patients
T19	Concept 288 297	elevation
T20	Concept 305 311	levels
T23	Concept 327 337	myocardial
T24	Concept 338 345	enzymes
T25	Concept 350 357	markers
T26	Concept 361 371	myocardial
T27	Concept 372 378	damage
T28	Concept 696 704	COVID-19
T29	Concept 705 713	patients
T31	Concept 719 728	very high
T32	Concept 729 735	levels
T33	Concept 739 750	serum IL-10
T34	Concept 761 771	SARS-CoV-2
T35	Concept 772 781	infection
T36	Action 794 804	displaying
T37	Concept 805 809	high
T38	Concept 810 816	levels
T39	Concept 824 828	PD-1
T40	Concept 833 838	Tim-3
T42	Concept 839 857	exhaustion markers
T43	Concept 867 874	T cells
T44	Concept 953 958	rates
T45	Concept 962 967	early
T46	Concept 968 976	epidemic
T47	Concept 977 983	growth
T50	Concept 1002 1012	130 cities
T51	Concept 1016 1021	China
T52	Concept 1051 1059	COVID-19
T53	Concept 1060 1064	case
T54	Concept 1065 1073	imported
T55	Concept 1079 1084	Wuhan
T56	Concept 1092 1099	3 weeks
R15	in-context Arg1:T44 Arg2:T47	
R16	in-context Arg1:T47 Arg2:T46	
R17	has-property Arg1:T47 Arg2:T45	
R19	in-place Arg1:T50 Arg2:T51	
T48	Concept 1027 1038	â‰¥50% chance
T49	Action 1042 1048	having
R20	subject Arg1:T49 Arg2:T50	
R21	target Arg1:T49 Arg2:T53	
R22	in-context Arg1:T53 Arg2:T52	
R23	has-property Arg1:T53 Arg2:T54	
R24	in-place Arg1:T49 Arg2:T55	
R25	in-time Arg1:T49 Arg2:T56	
T57	Concept 1100 1109	preceding
T58	Concept 1114 1124	quarantine
R26	in-context Arg1:T56 Arg2:T57	
R27	in-context Arg1:T57 Arg2:T58	
R18	in-context Arg1:T29 Arg2:T28	
R29	has-property Arg1:T29 Arg2:T32	
R30	has-property Arg1:T32 Arg2:T31	
R31	in-context Arg1:T32 Arg2:T33	
T30	Action 1022 1026	have
R33	causes Arg1:T44 Arg2:T30	
R34	subject Arg1:T30 Arg2:T50	
R35	target Arg1:T30 Arg2:T48	
R32	in-context Arg1:T48 Arg2:T49	
T59	Action 751 760	following
R28	subject Arg1:T59 Arg2:T29	
R36	target Arg1:T59 Arg2:T35	
R37	in-context Arg1:T35 Arg2:T34	
R38	subject Arg1:T36 Arg2:T29	
R39	target Arg1:T36 Arg2:T38	
R40	has-property Arg1:T38 Arg2:T37	
R42	in-context Arg1:T38 Arg2:T42	
R43	in-context Arg1:T42 Arg2:T40	
R44	in-context Arg1:T42 Arg2:T39	
R41	in-place Arg1:T42 Arg2:T43	
T41	Action 876 886	suggesting
T60	Concept 892 897	IL-10
T62	Concept 907 922	mechanistically
T63	Concept 923 934	responsible
R46	has-property Arg1:T60 Arg2:T63	
R47	in-context Arg1:T63 Arg2:T62	
R48	entails Arg1:T36 Arg2:T60	
R45	in-context Arg1:T18 Arg2:T17	
R49	in-place Arg1:T19 Arg2:T20	
R50	has-property Arg1:T18 Arg2:T19	
R51	in-context Arg1:T20 Arg2:T24	
R52	in-context Arg1:T24 Arg2:T23	
R53	in-context Arg1:T20 Arg2:T25	
R54	in-context Arg1:T25 Arg2:T27	
R55	in-context Arg1:T27 Arg2:T26	
T21	Concept 385 393	features
R56	has-property Arg1:T18 Arg2:T21	
T22	Action 402 406	meet
A2	Negated T22
R57	subject Arg1:T22 Arg2:T21	
T61	Concept 418 428	definition
T64	Concept 411 417	strict
R58	has-property Arg1:T61 Arg2:T64	
R59	target Arg1:T22 Arg2:T61	
T65	Concept 432 449	myocardial injury
R60	in-context Arg1:T61 Arg2:T65	
T67	Concept 487 495	NCP type
T68	Concept 480 486	common
T69	Action 500 512	experiencing
T70	Concept 513 518	quick
T71	Concept 519 527	recovery
R62	has-property Arg1:T21 Arg2:T67	
R63	has-property Arg1:T67 Arg2:T68	
R64	subject Arg1:T69 Arg2:T21	
R61	target Arg1:T69 Arg2:T71	
R65	has-property Arg1:T71 Arg2:T70	
T66	Concept 538 544	58.33%
T72	Concept 554 562	patients
R66	in-context Arg1:T66 Arg2:T72	
T73	Action 563 572	exhibited
T74	Concept 573 587	LV dysfunction
R67	subject Arg1:T73 Arg2:T66	
R68	target Arg1:T73 Arg2:T74	
T75	Concept 591 595	echo
R69	in-place Arg1:T73 Arg2:T75	
T76	Concept 601 610	long-term
T77	Concept 611 619	outcomes
T78	Action 620 638	should be observed
R70	target Arg1:T78 Arg2:T77	
R71	has-property Arg1:T77 Arg2:T76	
T79	Concept 658 664	future
T80	Concept 665 670	study
R73	in-time Arg1:T80 Arg2:T79	
R74	in-context Arg1:T78 Arg2:T80	
